Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
Vanguard Capital Management LLC reported a 7.37% stake in Regeneron Pharmaceuticals, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 30, 2026
Vanguard Capital Management LLC reported a 7.37% stake in Regeneron Pharmaceuticals, Inc., 7,660,810 shares, as a passive investor on Mar 31, 2026. Filed Apr 30, 2026 (Schedule 13G).
- Stake
- 7.37%
- Shares
- 7,660,810
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 7.37% | 7,660,810 |
Source
Related
- Regeneron Pharmaceuticals, Inc.
- Vanguard Capital Management LLC
- Regeneron Pharmaceuticals, Inc. shareholders
- Form 4 · Murphy Andrew J · Oct 15, 2026
- Form 4 · McCourt Marion · Sep 3, 2026
- Form 4 · Guarini Kathryn · Sep 3, 2026
- Form 4 · Larosa Joseph J · Aug 21, 2026
- Form 4 · Fenimore Christopher R. · Aug 20, 2026